WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 ฿
0,00%
(0,00) 1D
15 okt, 16:40:00 GMT+7 · THB
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
insights_autoWUXI06 üçün ən vacib statistik məlumatlar yaradılır...
Açın
5,25 ฿
Yüksək
5,35 ฿
Aşağı
5,05 ฿
Bazar kapitalizasiyası
200,24 mlrd
Ortalama həcm
93,60K
Həcm
288,50K
52 həftəlik ən yüksək
6,25 ฿
52 həftəlik ən aşağı
3,02 ฿
Dövriyyədəki səhmlər
4,12 mlrd
İşçilərin sayı
15K
Açın
5,25 ฿
Yüksək
5,35 ฿
Aşağı
5,05 ฿
Bazar kapitalizasiyası
200,24 mlrd
Ortalama həcm
93,60K
Həcm
288,50K
52 həftəlik ən yüksək
6,25 ฿
52 həftəlik ən aşağı
3,02 ฿
Dövriyyədəki səhmlər
4,12 mlrd
İşçilərin sayı
15K
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
Seeking Alpha
·
1 saat öncə
Today’s ‘stealth’ bear market is ‘one of the most significant opportunities’ – The Kobeissi Letter
Simply Wall Street
·
24 dəqiqə öncə
Wix Stock Faces A Real Test After AI Payments Launch
www.marketscreener.com
·
4 dəqiqə öncə
S&P 500 ends higher as traders shift from AI to healthcare
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics (Cayman) Inc. KKPS DR haqqında
Baş İcraçı DirektorZhisheng Chen
İşçilər14,7K
Təsis Tarixi2010
Baş Ofis-
SektorHealth care
Veb-saytwuxibiologics.com